SELECTIVE ESTROGEN RECEPTOR MODULATOR COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE
申请人:Scanlan Thomas S.
公开号:US20090124698A1
公开(公告)日:2009-05-14
The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
[EN] DEVELOPMENT OF NEW SELECTIVE ESTROGEN RECEPTOR MODULATORS<br/>[FR] DEVELOPPEMENT DE NOUVEAUX MODULATEURS SELECTIFS DU RECEPTEUR D'OESTROGENES
申请人:UNIV CALIFORNIA
公开号:WO2005041946A1
公开(公告)日:2005-05-12
The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
Nickel-Catalyzed Arylative Carboxylation of Alkynes with Arylmagnesium Reagents and Carbon Dioxide Leading to Trisubstituted Acrylic Acids
作者:Sheng Wang、Chanjuan Xi
DOI:10.1021/acs.orglett.8b01693
日期:2018.7.6
Nickel-catalyzed arylcarboxylation of alkynes with arylmagnesium reagents and carbondioxide (CO2, 1 atm) was realized in one pot. Various trisubstitutedacrylicacids within an aryl group at the β-position have been prepared efficiently with good regioselectivity under mild conditions. The resulting products could be further transformed to benzoannelated cycles retaining CO2 as a one-carbon synthon
Development of new selective estrogen receptor modulators
申请人:Scanlan S. Thomas
公开号:US20050113453A1
公开(公告)日:2005-05-26
The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.